Corporate | 5 September 2008 11:07
ECKERT & ZIEGLER Strahlen- und Medizintechnik AG / Acquisition
Release of a Corporate News, transmitted by DGAP - a company of EquityStory
AG.
The issuer / publisher is solely responsible for the content of this announcement.
----------------------------------------------------------------------
Berlin, September 5, 2008 - Eckert & Ziegler Strahlen- und Medizintechnik
AG, through its Californian subsidiary Eckert & Ziegler Isotope Products,
Inc (EZIP), has entered into a definite agreement with North American
Scientific (NASM) for the purchase of its Non-Therapeutic Sealed Source
Business. The product line includes radiation sources and standards used in
a variety of areas for calibration, measurement, analysis and control. The
transaction value, if certain revenue targets are met, can reach up to $6
million.
'Eckert & Ziegler Isotope Products is very excited to be adding the NASM
Sealed Source portfolio to our own. NASM has many outstanding technologies
that perfectly complement ours. With the addition of the Featherlite™ to
the Perflexion™, we believe that we have the two leading product
technologies for Co57 Flood Sources', said Frank Yeager, President & CEO of
Eckert & Ziegler Isotope Products.
'The acquisition will allow our strongest and most profitable segment, the
Medical Imaging and Industrial Segment, to show double digit growth in
revenues and profits in 2009', adds Andreas Eckert, CEO of Eckert & Ziegler
AG. 'We are hence optimistic that the group will be able to continue its
historic growth rates.'
'This divestiture allows us the opportunity to focus solely on growing the
therapeutic areas of our business', said John Rush, President and CEO of
North American Scientific. 'Eckert & Ziegler is a market leader in the
non-therapeutic radioisotope business. They will serve our customers as
well or better than we would be capable of moving forward. This transaction
is a win-win for all involved.'
For over forty (40) years, Eckert & Ziegler Isotope Products, has been
producing instrumentation and calibration standards. Today it is the
world's leading manufacturer for nuclear imaging reference and calibration
standards and a leading producer of radioactive components for industrial,
scientific and medical applications.
Eckert & Ziegler AG is a global isotope technology company that processes
radioisotopes as well as develops, manufactures and sells isotope
technology components, medical technology equipment and related products.
The group employs about 430 people worldwide. Throughout all of its
subsidiaries it generates yearly consolidated revenues in excess of $ 100
MM (70 Mio. EUR). Eckert & Ziegler AG is listed in the Prime Standard of
the German Stock Exchange in Frankfurt am Main (ISIN DE0005659700).
The Executive Board
For further information, please contact:
Eckert & Ziegler Isotope Products Inc.:
24937 Avenue Tibbitts
Valencia, California 91355
T: 661.309.1010
F. 661.257.8308
Media contact:
Melanie Harrison
T: 661.309.1060
E : melanie.harrison@ezag.com
Europäische Niederlassung:
Eckert & Ziegler Isotope Products GmbH
Robert-Rössle-Strasse 10
D-13125 Berlin-Buch
Germany
T: +44 (0) 30.94.10.84.0
F: +49 (0) 30.94.10.84.320
E: martin.hughes@ezag.com
05.09.2008 Financial News transmitted by DGAP
----------------------------------------------------------------------
Language: English
Issuer: ECKERT & ZIEGLER Strahlen- und Medizintechnik AG
Robert-Rössle-Str. 10
13125 Berlin
Deutschland
Phone: +49 (0)30 941 084-0
Fax: +49 (0)30 941 084-112
E-mail: thomas.scheuch@ezag.de
Internet: www.ezag.de
ISIN: DE0005659700
WKN: 565970
Listed: Regulierter Markt in Frankfurt (Prime Standard), Stuttgart;
Freiverkehr in Berlin, München, Hamburg, Düsseldorf
End of News DGAP News-Service
---------------------------------------------------------------------------